#South Korea #blood pressure #Sky Labs #CART BP pro #Gdańsk, Manchester

Sky Labs' Revolutionary 'CART BP pro'

Sky Labs, a leading health tech company based in South Korea, has unveiled its latest innovation, the 'CART BP pro', at two significant symposiums: the 35th European Society of Hypertension (ESH) in Gdańsk, Poland, and the British Cardiovascular Society (BCS) Annual Conference in Manchester, England. This ring-type cuffless blood pressure monitor is touted as a potential global “game changer” in hypertension management, especially after the Korean Society of Hypertension (KSH) endorsed cuffless devices for out-of-office monitoring in their updated guidelines.

The CART BP pro has garnered significant attention among the global medical community, especially given its alignment with cutting-edge blood pressure guidelines. As the first of its kind to receive validation from the KSH, the device leverages clinically validated technologies to meet and exceed the requirements of traditional blood pressure monitoring methods.

The device conforms to international standards (ISO 81060-2:2018), which was a major point highlighted in presentations during the symposiums. It has undergone rigorous testing, including Static Test, Device Position Test, Awake/Asleep Test, and Exercise Test, to validate its efficacy as a reliable health monitoring tool. As of May 2026, CART BP pro has received over 260,000 prescriptions in South Korea, demonstrating a rapid acceptance and trust from healthcare professionals.

International experts, including Professor George Stergiou, President of the International Society of Hypertension, have noted South Korea’s proactive approach as they explore the real-world applications of cuffless devices. Stergiou remarked on the importance of not just assessing device accuracy, but its capacity to improve patient outcomes, thus highlighting the CART BP pro’s innovative edge.

Professor Kwang-Il Kim, President of the Korean Society of Hypertension, echoed this sentiment by emphasizing the favorable conditions in South Korea for the swift adoption of innovative medical devices, pointing out that the comprehensive healthcare system reduces the financial burden on patients, facilitating greater access and adherence to advanced treatments.

The unique ring-type design of the CART BP pro not only enhances patient comfort but also minimizes the disturbances typically associated with traditional cuff-based monitors, especially during nighttime usage. This innovation positions the device as a highly accepted option among patients, potentially revolutionizing how blood pressure monitoring is approached in various medical contexts.

Sky Labs has also made significant regulatory strides, obtaining CE-MDR certification in January of this year, followed by registration with the UK's Medicines and Healthcare products Regulatory Agency (MHRA). These achievements pave the way for a strategic expansion into European markets, bolstering their mission to emerge as a leader in global healthcare solutions.

Founded in 2015, Sky Labs is committed to developing and operating health monitoring technologies aimed at improving the management of chronic diseases. Their portfolio includes the CART BP pro alongside the newly launched consumer-grade 'CART BP', a more accessible version of their blood pressure monitoring technology.

As healthcare systems worldwide continue to prioritize patient-centered innovations, the potential impact of the CART BP pro cannot be understated. By ushering in a new era of cuffless blood pressure monitoring, Sky Labs is well-positioned to lead advancements in hypertension management, promoting better health outcomes across diverse populations. As they prepare for broader market penetration, the medical community eagerly anticipates the results of CART BP pro’s real-world applications and its influence on global practices in blood pressure monitoring.